Multiple sclerosis changes how large brain networks talk to each other, with some areas talking more and others less, which helps explain symptoms like movement, thinking, and vision problems.
Researchers looked at 25 brain imaging studies comparing people with MS to healthy people and found consistent changes in several large brain networks. Some brain areas showed stronger connections than normal (for example parts of the default mode network, which is active when the mind rests, and parts of the motor network, which controls movement), while other areas showed weaker connections (for example the back part of the default mode network and parts of the motor and visual networks). Think of the brain like a city: some roads (connections) became busier while others became quieter, and traffic patterns were reorganized. These changes were found across many people with MS, suggesting they are part of the disease itself rather than random differences. The study did not find a clear link between these connection changes and how long someone had MS or how severe their disability was, based on the data available.
People with MS and their caregivers should care because these brain network changes help explain common symptoms like trouble walking, weakness, vision problems, fatigue, and thinking difficulties. For example, when the motor network is less connected it’s like a delivery truck losing GPS signal — movement commands may be slower or less accurate. Healthcare providers and therapists can use this idea to think about treatments that target brain function (such as specific rehabilitation exercises, cognitive training, or therapies that support brain health) in addition to controlling inflammation. Researchers benefit too, because understanding these patterns can guide development of new tests or therapies that aim to restore better balance in brain networks. Overall, knowing that MS affects how brain networks reorganize helps set expectations and guide practical approaches to symptom management at home and in clinic.
This study combined results from many different research groups that used slightly different methods and patient samples, so not every finding applies to every person with MS. The analysis did not find clear links between the brain connection changes and clinical measures like disease duration or disability score, so we can’t yet use these brain patterns to predict individual outcomes. Also, imaging studies show patterns at the group level but don’t tell us whether changing these connections will directly improve symptoms — that needs more research.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.